3 This expanded label indication for type 2 diabetes is based ... The Company’s pump portfolio features the Tandem Mobi ...

Tandem is following competitor Insulet’s lead with the second automated insulin delivery system indicated for Type 2 diabetes ...

Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults ...

Tandem Diabetes Care, Inc.’s Control-IQ+ Technology, used with the t:slim and Mobi insulin pumps, becomes the second AID ...

The US Food and Drug Administration (FDA) has cleared Tandem Diabetes Care’s Control-IQ+ technology, an automated insulin ...

Tandem Diabetes Care announced that the FDA cleared its Control-IQ+ automated insulin delivery algorithm for people with type ...

Tandem is hoping that the experimental predictive low glucose suspend (PLGS) feature on its t:slim X2 insulin pump will give it the edge. The company has been updating features on its pump over ...

SAN DIEGO, February 25, 2025--(BUSINESS WIRE)--Tandem ... pump brand by both healthcare providers and people living with type 1 diabetes to adults with type 2." 1,2 This expanded label indication ...

1,2 This expanded label indication for type 2 diabetes ... The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced ...